The Sentinel

THE OFFICIAL BLOG OF THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC).

Tuesday, June 4, 2019

President's Message - June 2019

Dear Colleagues,

For 35 years, a primary purpose of the Society for Immunotherapy of Cancer (SITC) – through its growth and multiple iterations – has been to bring together top scientists and clinicians in our field. SITC has served as the catalyst for these professionals to convene and share their latest research achievements, and through interaction and collaboration, to spur future advances and breakthroughs in the field.

Our organization was originally founded in 1984 by 40 charter members as the Society for Biological Therapy (SBT). In the past 35 years, much has changed, both in immuno-oncology and our society, including our name. SITC has grown with the field – eclipsing 2,400 members in 2018 – and remains at the forefront of scientific and clinical advances in cancer immunotherapy.

Beginning tomorrow, June 1, SITC will join our colleagues at the Cancer Research Institute to celebrate Cancer Immunotherapy Awareness Month™. During this month, we will bring attention to the many ways our society, through the contributions and dedication of its members, seeks to educate health care professionals and patients, and to enable research that will yield our field’s next breakthroughs. On our website and various social media channels, including Twitter and Facebook, SITC will feature a different program, resource or SITC initiative each day of the month. These activities are designed to create awareness of cancer immunotherapy and the depth and breadth of our society’s contributions to the field.

Also, on Friday, June 14, please join me in wearing white to honor and celebrate the work of the many researchers and clinicians in our field. Please consider purchasing a SITC Cure T-shirt, through a donation to the SITC Forward Fund, to wear on June 14, and then download our “Why I Wear White” flyer to share what drives your commitment to the cancer immunotherapy field. For me, every patient in my clinic who is alive today only because he or she received interleukin-2, or anti-PD-1 and or anti-CTLA-4, and every patient I see for whom these therapies were not enough to provide benefit, is another reminder of why I am committed to advancing these therapies in the clinic, and why I wear white on June 14. Take a selfie or group photo and tag SITC on social media to help us spread the word about cancer immunotherapy research.

As a final reminder, for those of you who will be in Chicago this weekend, please consider joining SITC at Buddy Guy’s Legends (700 S. Wabash Ave.) on Sunday, June 2, for the return to the stage of The CheckPoints, SITC’s house band. Doors open at 8 p.m. for The CheckPoints: Rockin' for a Cure, SITC’s annual fundraiser for the Forward Fund.

Sincerely,














Mario Sznol, MD
SITC President